|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cohen PA, Jhingran A, Oaknin A and Denny
L: Cervical cancer. Lancet. 393:169–182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Crosbie EJ, Einstein MH, Franceschi S and
Kitchener HC: Human papillomavirus and cervical cancer. Lancet.
382:889–899. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hoppe-Seyler K, Bossler F, Braun JA,
Herrmann AL and Hoppe-Seyler F: The HPV E6/E7 oncogenes: Key
factors for viral carcinogenesis and therapeutic targets. Trends
Microbiol. 26:158–168. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bertoli C, Skotheim JM and de Bruin RA:
Control of cell cycle transcription during G1 and S phases. Nat Rev
Mol Cell Biol. 14:518–528. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Suryadinata R, Sadowski M and Sarcevic B:
Control of cell cycle progression by phosphorylation of
cyclin-dependent kinase (CDK) substrates. Biosci Rep. 20:243–255.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu H, Gao Y, Wang Y, Liang C, Zhang Z and
Chen Y: LncRNA CRNDE promotes the progression and angiogenesis of
pancreatic cancer via miR-451a/CDKN2D axis. Transl Oncol.
14:1010882021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee HA, Chu KB, Moon EK and Quan FS:
Histone deacetylase inhibitor-induced CDKN2B and CDKN2D contribute
to G2/M cell cycle arrest incurred by oxidative stress in
hepatocellular carcinoma cells via forkhead box M1 suppression. J
Cancer. 12:5086–5098. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Jin W, Jia X, Luo R, Tan Y, Zhu X,
Yang X, Wang X and Wang K: Transcriptional repression of CDKN2D by
PML/RARα contributes to the altered proliferation and
differentiation block of acute promyelocytic leukemia cells. Cell
Death Dis. 5:e14312014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hosseini ES, Meryet-Figuiere M,
Sabzalipoor H, Kashani HH, Nikzad H and Asemi Z: Dysregulated
expression of long noncoding RNAs in gynecologic cancers. Mol
Cancer. 16:1072017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hosono Y, Niknafs YS, Prensner JR, Iyer
MK, Dhanasekaran SM, Mehra R, Pitchiaya S, Tien J, Escara-Wilke J,
Poliakov A, et al: Oncogenic role of THOR, a conserved
cancer/testis long non-coding RNA. Cell. 171:1559–1572.e20. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mondal T, Juvvuna PK, Kirkeby A, Mitra S,
Kosalai ST, Traxler L, Hertwig F, Wernig-Zorc S, Miranda C, Deland
L, et al: Sense-antisense lncRNA pair encoded by locus 6p22.3
determines neuroblastoma susceptibility via the USP36-CHD7-SOX9
regulatory axis. Cancer Cell. 33:417–434.e7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li C, Wang S, Xing Z, Lin A, Liang K, Song
J, Hu Q, Yao J, Chen Z, Park PK, et al: A ROR1-HER3-lncRNA
signalling axis modulates the Hippo-YAP pathway to regulate bone
metastasis. Nat Cell Biol. 19:106–119. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin A, Hu Q, Li C, Xing Z, Ma G, Wang C,
Li J, Ye Y, Yao J, Liang K, et al: The LINK-A lncRNA interacts with
PtdIns(3,4,5)P3 to hyperactivate AKT and confer
resistance to AKT inhibitors. Nat Cell Biol. 19:238–251. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Y, Yang Y, Li L, Liu Y, Geng P, Li G
and Song H: LncRNA SNHG1 enhances cell proliferation, migration,
and invasion in cervical cancer. Biochem Cell Biol. 96:38–43. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rui X, Xu Y, Huang Y, Ji L and Jiang X:
LncRNA DLG1-AS1 promotes cell proliferation by competitively
binding with miR-107 and up-regulating ZHX1 expression in cervical
cancer. Cell Physiol Biochem. 49:1792–1803. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Manawapat-Klopfer A, Thomsen LT, Martus P,
Munk C, Russ R, Gmuender H, Frederiksen K, Haedicke-Jarboui J,
Stubenrauch F, Kjaer SK and Iftner T: TMEM45A, SERPINB5 and
p16INK4A transcript levels are predictive for development of
high-grade cervical lesions. Am J Cancer Res. 6:1524–1536.
2016.PubMed/NCBI
|
|
19
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Camp RL, Dolled-Filhart M and Rimm DL:
X-tile: A new bio-informatics tool for biomarker assessment and
outcome-based cut-point optimization. Clin Cancer Res.
10:7252–7259. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Terry MT and Patricia MG: Modeling
survival data: Extending the cox model. Springer; New York: ISBN
0-387-98784-3; pp. 261–287. 2000
|
|
22
|
Kassambara A, Kosinski M and Biecek P:
Drawing survival curves using ‘ggplot2’ [r package survminer
version 0.4.8]. 2020.
|
|
23
|
Percie du Sert N, Hurst V, Ahluwalia A,
Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl
U, et al: The ARRIVE guidelines 2.0: Updated guidelines for
reporting animal research. PLoS Biol. 18:e30004102020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals, . Guide for the Care and Use of Laboratory Animals. 8th
edition. National Academies Press; Washington, DC: 2011
|
|
26
|
Liontos M, Kyriazoglou A, Dimitriadis I,
Dimopoulos MA and Bamias A: Systemic therapy in cervical cancer: 30
Years in review. Crit Rev Oncol Hematol. 137:9–17. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu W, Wang Z, Liu L, Yang Z, Liu S, Ma Z,
Liu Y, Ma Y, Zhang L, Zhang X, et al: LncRNA Malat1 inhibition of
TDP43 cleavage suppresses IRF3-initiated antiviral innate immunity.
Proc Natl Acad Sci USA. 117:23695–23706. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma Y, Yang Y, Wang F, Moyer MP, Wei Q,
Zhang P, Yang Z, Liu W, Zhang H, Chen N, et al: Long non-coding RNA
CCAL regulates colorectal cancer progression by activating
Wnt/β-catenin signalling pathway via suppression of activator
protein 2α. Gut. 65:1494–1504. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang ZW, Chen JJ, Xia SH, Zhao H, Yang
JB, Zhang H, He B, Jiao J, Zhan BT and Sun CC: Long intergenic
non-protein coding RNA 319 aggravates lung adenocarcinoma
carcinogenesis by modulating miR-450b-5p/EZH2. Gene. 650:60–67.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chi Y, Wang D, Wang J, Yu W and Yang J:
Long non-coding RNA in the pathogenesis of cancers. Cells.
8:10152019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hu G, Niu F, Humburg BA, Liao K, Bendi S,
Callen S, Fox HS and Buch S: Molecular mechanisms of long noncoding
RNAs and their role in disease pathogenesis. Oncotarget.
9:18648–18663. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Felisiak-Golabek A, Dansonka-Mieszkowska
A, Rzepecka IK, Szafron L, Kwiatkowska E, Konopka B, Podgorska A,
Rembiszewska A and Kupryjanczyk J: p19(INK4d) mRNA and protein
expression as new prognostic factors in ovarian cancer patients.
Cancer Biol Ther. 14:973–981. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zang WQ, Yang X, Wang T, Wang YY, Du YW,
Chen XN, Li M and Zhao GQ: MiR-451 inhibits proliferation of
esophageal carcinoma cell line EC9706 by targeting CDKN2D and
MAP3K1. World J Gastroenterol. 21:5867–5876. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bartkova J, Thullberg M, Rajpert-De Meyts
E, Skakkebaek NE and Bartek J: Lack of p19INK4d in human testicular
germ-cell tumours contrasts with high expression during normal
spermatogenesis. Oncogene. 19:4146–4150. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Alzahrani AS: PI3K/Akt/mTOR inhibitors in
cancer: At the bench and bedside. Semin Cancer Biol. 59:125–132.
2019. View Article : Google Scholar : PubMed/NCBI
|
